AGC Biologics to Manufacture Teikoku’s rhMMP-7
HEIDELBERG, Germany and CHIBA, Japan, May 26, 2026 HEIDELBERG, Germany and CHIBA, Japan, May 26, 2026 — AGC Biologics...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
HEIDELBERG, Germany and CHIBA, Japan, May 26, 2026 HEIDELBERG, Germany and CHIBA, Japan, May 26, 2026 — AGC Biologics...
HUNTSVILLE, Ala. and KASSEL, Germany, May 20, 2026 Discovery Life Sciences has launched Luminos® Comprehensive, a next-generation IVDR-compliant clinical...
JERUSALEM, Israel, May 20, 2026 Scinai Immunotherapeutics Ltd. has announced the appointment of Eilon Elmalem as the new Site...
SEOUL, South Korea, May 18, 2026 LOTTE Biologics announced an expanded antibody manufacturing collaboration with Ottimo Pharma to support...
COLUMBUS, Ohio, May 13, 2026 Andelyn Biosciences announced that it has received full certification under the Initiative for Certification...
PHILADELPHIA, May 4, 2026 Lannett Company, Inc., through its subsidiary Lanexa Biologics in partnership with Sunshine Lake Pharma, has...
San Diego, California, USA, April 6, 2026 Commercial-Scale Manufacturing Readiness Demonstrated In a significant advancement for biologics manufacturing and...
INCHEON, South Korea & ROCKVILLE, Maryland, USA — March 31, 2026 Samsung Biologics has officially completed the acquisition of...
Brussels, Belgium & Atlanta, Georgia – March 24, 2026 Strategic Biologics Expansion to Strengthen Global Supply In a major...
KING OF PRUSSIA, Pa., March 9, 2026 CSL Limited, a global biopharmaceutical leader, has announced a $1.5 billion investment...
